-
124
-
96
-
49
-
47
-
44
Vol. 1 No. 9: 3rd International Conference on Thrombosis and Hemostasis Issues in Cancer, Bergamo, October 14-16, 2005
Published:
2009-06-03
Articles
-
The scale of the problem
Published: June 3, 2009141PDF: 155 -
Occult cancer and idiopathic venous thromboembolism
Published: June 3, 2009161PDF: 610 -
Tissue factor-bearing microparticles and cancer-associated thrombosis
Published: June 3, 2009201Untitled (): 0 -
Blood-borne tissue factor
Published: June 3, 2009231PDF: 258 -
Tissue factor pathway inhibitor and cancer
Published: June 3, 2009157PDF: 597 -
Tissue factor-PAR2 signaling crosstalk in cancer and angiogenesis
Published: June 3, 2009165PDF: 426 -
Oncogenic events regulating tissue factor expression
Published: June 3, 2009165PDF: 297 -
Hemostatic factors support metastasis by impeding NK cell-mediated elimination of embolic tumor cells
Published: June 3, 2009206PDF: 332 -
The met oncogene drives a genetic program linking cancer to hemostasis
Published: June 3, 2009148PDF: 231 -
Cytokine GRO-a is pivotal in thrombin-induced angiogenesis
Published: June 3, 2009177PDF: 333 -
Low molecular weight heparin and survival in cancer
Published: June 3, 2009163PDF: 166 -
Fibrinolytics, enzyme inhibitors, and cancer survival
Published: June 3, 2009159PDF: 646 -
Vitamin k, warfarin and prothrombin: an alternate pathway to improve cancer survival
Published: June 3, 2009170PDF: 235 -
Future perspective of clinical trials of antithrombotics and cancer survival
Published: June 3, 2009138PDF: 163 -
Clinical trials with angiogenesis inhibitors
Published: June 3, 2009169PDF: 172 -
Vascular complications of endothelium targeting therapies
Published: June 3, 2009154PDF: 160 -
Commentary on thrombotic and bleeding complications of clinical trials of growth factor inhibitors
Published: June 3, 2009137PDF: 690 -
Lymphangiogenesis: a new paradigm for cancer progression and therapy
Published: June 3, 2009129PDF: 149 -
Hemorrhage and thrombosis in acute leukemia
Published: June 3, 2009383PDF: 3597 -
Prevention of disseminated intravascular coagulation in cancer
Published: June 3, 2009386PDF: 1273 -
Bleeding and thrombosis in childhood cancer
Published: June 3, 2009157PDF: 634 -
The protein C system in inflammation and cancer: a critical role for thrombomodulin
Published: June 3, 2009151PDF: 180 -
Heparin effects in metastasis and Trousseau's syndrome: anticoagulation is not the primary mechanism
Published: June 3, 2009298PDF: 197 -
The impact of heparanase on cancer progression
Published: June 3, 2009179PDF: 704 -
Inhibition of tumor growth by heparins in vivo
Published: June 3, 2009136PDF: 174 -
Clinical outcomes in cancer patients with concurrent venous thromboembolism: findings from the RIETE registry
Published: June 3, 2009195PDF: 492 -
Unresolved problems in venous thromboembolism treatment in cancer
Published: June 3, 2009159PDF: 392 -
The role of new antithrombotics
Published: June 3, 2009122PDF: 94 -
Modified Heparins as possible inhibitors of metastasis
Published: June 3, 2009122PDF: 353